← SynDRA
NIMODIPINE
SynDRA canonical compound SYN0006441 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | CACNA1S |
|---|
| Mechanism of action | Calcium channel blocker |
|---|
| Indication | hemorrhage |
|---|
| Disease area | hematology |
|---|
All known targets
- NR3C2
- CACNA1C
- CACNA1F
- CACNA1S
- CACNA1D
- CFTR
- ABCG2
- Cacna1c
- PDE4D
- PDE1C
- P2RX4
- NR1I2
Mechanisms of action (all sources)
- Calcium channel blocker
- NR3C2 ANTAGONIST
- Mineralocorticoid receptor antagonist
- CACNA1C BLOCKER
- Voltage-gated L-type calcium channel blocker
- CACNA1S BLOCKER
- CACNA1D BLOCKER
- CACNA1F BLOCKER
- CACNA1S ANTAGONIST
- CACNA1F ANTAGONIST
- CFTR POTENTIATION
- P2RX4 POSITIVE ALLOSTERIC MODULATOR
Drug classes
- Calcium Channel Antagonists
- Dihydropyridine Calcium Channel Blocker
- Antihypertensive Agents
- Calcium Channel Blockers
- Calcium-Regulating Hormones and Agents
- Cardiovascular Agents
- Membrane Transport Modulators
- Vasodilator Agents
ATC classes
- C08C · SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS
Cross-references
Synonyms
- nemotan
- nymalize
- Nimodipino
- Admon
- Nemotan
- Nimodipine ap
- Periplum
- BAY-E-9736
- NSC-758476
- Nimotop
- Nymalize
- Brainal
- Calnit
- Kenesil
- Modus
- NimoGel
- NimodipinISIS
- Nimodipinum
- Remontal
- Almirall Brand of Nimodipine
- Alpharma Brand of Nimodipine
- Andromaco Brand of Nimodipine
- Bayer Brand of Nimodipine
- Bayvit Brand of Nimodipine
- Cantabria Brand of Nimodipine
- Elan Brand of Nimodipine
- Esteve Brand of Nimodipine
- Hexal Brand of Nimodipine
- Nimodipin Hexal
- Nimodipin-ISIS
- Nimodipino Bayvit
- Vita Brand of Nimodipine
- Bay-e-9736
- DRG-0139
- EG-1961
- N-149
- NIMOTOP (TN)
- Nimodipino [INN-Spanish]
Reported adverse events
- Bradycardia
- Nausea
- Tachycardia
- Acne
- Depression
- Headache
- Rash
- Hypotension
Look up NIMODIPINE in the interactive SynDRA portal →